Guillain-Barre syndrome

Clinical trials for Guillain-Barre syndrome explained in plain language.

Never miss a new study

Get alerted when new Guillain-Barre syndrome trials appear

Sign up with your email to follow new studies for Guillain-Barre syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

Could a drug speed recovery from Guillain-Barré syndrome?

Disease control Completed

This Phase 3 trial tested the drug eculizumab in 57 people with severe Guillain-Barré syndrome (GBS), a rare nerve disorder that can cause paralysis. Participants received either eculizumab or a placebo once a week for four weeks, alongside standard treatment. The study measured …

Matched conditions: GUILLAIN-BARRE SYNDROME

Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 26, 2026 14:47 UTC

Guillain-Barre syndrome

Get alerted when new Guillain-Barre syndrome trials appear

Could a drug speed recovery from Guillain-Barré syndrome?